COVID-19 and ENT SLT services, workforce and research in the UK: A discussion paper.
Joanne M PattersonRoganie GovenderJustin W G RoeGemma M ClunieJennifer MurphyGráinne C BradyJemma HainesAnna WhitePaul N CardingPublished in: International journal of language & communication disorders (2020)
The immediate impact of the pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. It is unclear when any of these areas will resume operations and whether permanent changes to clinical practice, professional remits and research priorities will follow. However, significant opportunity exists in the post-COVID era to re-evaluate current practice, embrace opportunities and evaluate new ways of working. What this paper adds What is already known on the subject ENT/laryngology SLTs manage patients with a range of conditions, including voice disorders, airway problems and HNCs. The diverse scope of clinical practice involves highly specialized assessment and treatment practices in patients in high-risk categories. A large majority of active research projects in this field are patient focused and involve instrumental assessment. The COVID-19 pandemic has created both opportunities and threats for ENT SLT clinical services, workforce and research. What this paper adds to existing knowledge This study provides a discussion of the threats and opportunities from the COVID-19 pandemic for ENT/laryngology SLT with specific reference to clinical practice, workforce and research leadership. What are the potential or actual clinical implications of this work? The COVID-19 pandemic has resulted in major disruption to all aspects of clinical delivery, workforce and research for ENT/laryngology SLT. Changes to clinical practice, professional remits and research priorities are of indeterminant duration at this time, and some components could be permanent. Significant clinical practice, workforce and research opportunities may exist in the post-COVID era.
Keyphrases
- clinical practice
- coronavirus disease
- public health
- sars cov
- healthcare
- primary care
- mental health
- end stage renal disease
- chronic kidney disease
- ejection fraction
- quality improvement
- respiratory syndrome coronavirus
- cross sectional
- patient reported outcomes
- climate change
- replacement therapy
- combination therapy
- finite element